Your browser doesn't support javascript.
loading
Nicotinamide as a precursor for NAD+ prevents apoptosis in the mouse brain induced by tertiary-butylhydroperoxide.
Klaidman, L K; Mukherjee, S K; Hutchin, T P; Adams, J D.
Afiliación
  • Klaidman LK; Department of Molecular Pharmacology and Toxicology, University of Southern California, School of Pharmacy 90033, USA.
Neurosci Lett ; 206(1): 5-8, 1996 Mar 08.
Article en En | MEDLINE | ID: mdl-8848280
The vitamin nicotinamide can protect against oxidative stress-induced apoptosis in the brain when used as a precursor for nicotinamide adenine dinucleotide (NAD+). The intracerebroventricular administration of tertiary-butylhydroperoxide (t-buOOH) to mice was used to simulate physiologic oxidative stress and apoptosis which may occur in some neurodegenerative conditions. t-buOOH produced characteristic apoptotic nuclear degeneration in neurons with extensive fragmentation of DNA. In this report we show that the elevation of NAD+ by nicotinamide prevents DNA fragmentation during apoptosis or necrosis in the brain as stimulated by t-buOOH administration. NAD+ levels can be increased by 50% in the brain. This may prevent the critical depletion of NAD+ by poly(ADP-ribose) polymerase (PARP) and provide additional substrate during the repair of DNA. Nicotinamide may be of particular interest in the treatment of neurodegeneration.
Asunto(s)
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Peróxidos / Encéfalo / Apoptosis / Niacinamida / NAD Límite: Animals Idioma: En Revista: Neurosci Lett Año: 1996 Tipo del documento: Article País de afiliación: Estados Unidos
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Peróxidos / Encéfalo / Apoptosis / Niacinamida / NAD Límite: Animals Idioma: En Revista: Neurosci Lett Año: 1996 Tipo del documento: Article País de afiliación: Estados Unidos